| [1] |
Gardner SD, Field AM, Coleman DV, et al. New human papovavirus(B.K.)isolated from urine after renal transplantation[J]. Lancet,1971,1(7712):1253-1257. http://cn.bing.com/academic/profile?id=1989209244&encoded=0&v=paper_preview&mkt=zh-cn
|
| [2] |
Bofill-Mas S, Formiga-Cruz M, Clemente-Casares P, et al. Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA[J]. J Virol,2001,75(21):10290-10299. doi: 10.1128/JVI.75.21.10290-10299.2001
|
| [3] |
Cole CN, Conzen SD. Polyomaviridae the viruses and their replication[M]//Knipe DM, Howley PM. Fields virology, Vol Ⅱ. Philadelphia: Lippinoctt Williams＆Wilkins, 2001: 2141-2157.
|
| [4] |
Tremolada S, Akan S, Otte J, et al. Rare subtypes of BK virus are viable and frequently detected in renal transplant recipients with BK virus-associated nephropathy[J]. Virology,2010,404(2):312-318. doi: 10.1016/j.virol.2010.05.012
|
| [5] |
Takasaka T, Goya N, Tokumoto T, et al. Subtypes of BK virus prevalent in Japan and variation in their transcriptional control region[J]. J Gen Virol,2004,85(Pt 10):2821-2827. http://cn.bing.com/academic/profile?id=2096039751&encoded=0&v=paper_preview&mkt=zh-cn
|
| [6] |
Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: correlation with graft outcome and viral load[J]. Am J Transplant,2004,4(12):2082-2092. doi: 10.1046/j.1600-6143.2004.00603.x
|
| [7] |
Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors[J]. J Infect Dis, 2009, 199(6):837-846. doi: 10.1086/598679
|
| [8] |
Brown DW, Gardner SD, Gibson PE, et al. BK virus specific IgM responses in cord sera, young children and healthy adults detected by RIA[J]. Arch Virol,1984,82(3/4):149-160. http://cn.bing.com/academic/profile?id=1999247511&encoded=0&v=paper_preview&mkt=zh-cn
|
| [9] |
邓伟明, 苗芸. 肾移植术后 BK 病毒相关性肾病的临床诊治研究进展[J].器官移植,2015,6(2):120-123,130. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201502011.htm
Deng WM, Miao Y. Clinical research progress on diagnosis and treatment of BK virus-associated nephropathy after renal transplantation[J]. Organ Transplant,2015,6(2):120-123,130. http://www.cnki.com.cn/Article/CJFDTOTAL-QGYZ201502011.htm
|
| [10] |
Alméras C, Vetromile F, Garrigue V, et al. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients[J]. Transpl Infect Dis, 2011, 13(2):101-108. doi: 10.1111/tid.2011.13.issue-2
|
| [11] |
Sood P, Senanayake S, Sujeet K, et al. Management and outcome of BK viremia in renal transplant recipients: a prospective single-center study[J]. Transplantation, 2012, 94(8):814-821. doi: 10.1097/TP.0b013e31826690c6
|
| [12] |
Hirsch HH, Vincenti F, Friman S, et al. Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study[J]. Am J Transplant,2013,13(1):136-145. doi: 10.1111/j.1600-6143.2012.04320.x
|
| [13] |
Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation[J]. Pediatr Nephrol, 2007, 22(9):1243-1250. doi: 10.1007/s00467-007-0462-x
|
| [14] |
Pham PT, Reddy UG. Transplantation: immunosuppression and risk of polyomavirus BK replication[J]. Nat Rev Nephrol,2013,9(3):135-136. doi: 10.1038/nrneph.2013.17
|
| [15] |
Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia[J]. Am J Transplant,2005,5(9):2213-2221. doi: 10.1111/ajt.2005.5.issue-9
|
| [16] |
Dadhania D, Snopkowski C, Ding R, et al. Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication[J]. Transplantation, 2008, 86(4):521-528. doi: 10.1097/TP.0b013e31817c6447
|
| [17] |
Sharif A, Alachkar N, Bagnasco S, et al. Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients[J]. Clin J Am Soc Nephrol, 2012,7(8):1320-1327. doi: 10.2215/CJN.00770112
|
| [18] |
Saundh BK, Baker R, Harris M, et al. Early BK polyomavirus (BKV) reactivation in donor kidney is a risk factor for development of BKV-associated nephropathy[J]. J Infect Dis, 2013, 207(1):137-141. doi: 10.1093/infdis/jis642
|
| [19] |
Masutani K, Ninomiya T, Randhawa P. HLA-A2, HLA-B44 and HLA-DR15 are associated with lower risk of BK viremia[J]. Nephrol Dial Transplant,2013, 28(12):3119-3126. doi: 10.1093/ndt/gft298
|
| [20] |
Hssig A, Roos M, Etter A, et al. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor[J]. Transpl Infect Dis, 2014, 16(1):44-54. doi: 10.1111/tid.2014.16.issue-1
|
| [21] |
Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy[J]. N Engl J Med, 2000, 342(18):1309-1315. doi: 10.1056/NEJM200005043421802
|
| [22] |
Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy[J]. J Am Soc Nephrol,2009,20(2):416-427. doi: 10.1681/ASN.2008010117
|
| [23] |
Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients[J]. N Engl J Med,2002,347(7):488-496. doi: 10.1056/NEJMoa020439
|
| [24] |
Kuppachi S, Thomas B, Kokko KE. BK virus in the kidney transplant patient[J]. Am J Med Sci,2013, 345(6):482-488. doi: 10.1097/MAJ.0b013e31826c64ef
|
| [25] |
Hirsch HH, Drachenberg CB, Steiger J, et al. Polyomavirus-associated nephropathy in renal transplantation: critical issues of screening and management[J]. Adv Exp Med Biol,2006,577:160-173. doi: 10.1007/0-387-32957-9
|
| [26] |
Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations[J]. Transplantation, 2005, 79(10):1277-1286. doi: 10.1097/01.TP.0000156165.83160.09
|
| [27] |
Viscount HB, Eid AJ, Espy MJ, et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy[J]. Transplantation, 2007, 84(3):340-345. doi: 10.1097/01.tp.0000275205.41078.51
|
| [28] |
Yeo FE, Yuan CM, Swanson SJ, et al. The prevalence of BK polyomavirus infection in outpatient kidney transplant recipients followed in a single center[J]. Clin Transplant,2008,22(5):532-541. doi: 10.1111/j.1399-0012.2008.00817.x
|
| [29] |
Boothpur R, Brennan DC. Human polyoma viruses and disease with emphasis on clinical BK and JC[J]. J Clin Virol, 2010, 47(4):306-312. doi: 10.1016/j.jcv.2009.12.006
|
| [30] |
Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients[J]. Am J Transplant, 2009,9 (Suppl 3):S1-S155. http://cn.bing.com/academic/profile?id=1990827591&encoded=0&v=paper_preview&mkt=zh-cn
|
| [31] |
Vasudev B, Hariharan S, Hussain SA, et al. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients[J]. Kidney Int,2005,68(4):1834-1839. doi: 10.1111/j.1523-1755.2005.00602.x
|
| [32] |
Wali RK, Drachenberg CB, Hirsch HH, et al. Intensive versus routine care screening for polyoma viral replication (cluster randomization) and a road map for stepwise modification of immunosuppression therapy (Abstract)[J]. Am J Transplant, 2008,8(Supl 2): 283.
|
| [33] |
Egli A, Köhli S, Dickenmann M, et al. Inhibition of polyomavirus BK-specific T-cell responses by immunosuppressive drugs[J]. Transplantation, 2009, 88(10):1161-1168. doi: 10.1097/TP.0b013e3181bca422
|
| [34] |
Johnston O, Jaswal D, Gill JS, et al. Treatment of polyomavirus infection in kidney transplant recipients: a systematic review[J]. Transplantation, 2010, 89(9):1057-1070. doi: 10.1097/TP.0b013e3181d0e15e
|
| [35] |
Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy[J]. Am J Transplant,2010,10(12):2615-2623. doi: 10.1111/ajt.2010.10.issue-12
|
| [36] |
Guasch A, Roy-Chaudhury P, Woodle ES, et al. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy[J]. Transplantation,2010,90(8):891-897. http://cn.bing.com/academic/profile?id=2017707529&encoded=0&v=paper_preview&mkt=zh-cn
|
Figures(1) / Tables(1)
WeChat Subscription Account
Wechat Service Account
Supported by:
Beijing Renhe Information Technology Co. Ltd
DownLoad: